| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 08/09/2006 | EP1687638A2 Analysis of mass spectral data in the quiet zones |
| 08/09/2006 | EP1687288A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 08/09/2006 | EP1687273A1 Process for preparation of chiral amlodipine salts |
| 08/09/2006 | EP1687269A1 Cosmetic process for preventing or treating the signs of skin ageing or the orange-peel appearance |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/09/2006 | EP1185267B1 Dermal anesthetic agents |
| 08/09/2006 | EP0877733B1 Process for production of piperidine derivatives |
| 08/09/2006 | CN1816544A Immunosuppressant compounds and compositions |
| 08/09/2006 | CN1816524A Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/09/2006 | CN1814589A Dermal anesthetic agents |
| 08/08/2006 | US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087749 Substituted piperidine compounds and methods of their use |
| 08/08/2006 | US7087622 Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| 08/08/2006 | US7087604 Antiarthritic agents;multiple sclerosis; anticholesterol agents; cardiovascular disorders |
| 08/08/2006 | US7087596 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 08/08/2006 | US7087239 For controlling phytopathogenic fungi or undesired attack by insects or mites and/or for regulating the growth of plants |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2006081280A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080477A1 Norvaline derivative and method for preparation thereof |
| 08/03/2006 | WO2006080415A1 Composition and method for treating or preventing bladder disorder |
| 08/03/2006 | WO2006079624A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 08/03/2006 | WO2006065479A3 Substituted phenols as active agents inhibiting vegf production |
| 08/03/2006 | WO2006034091A3 Process for production of carebastine |
| 08/03/2006 | WO2006032893A3 Trityl derivatives for enhancing mass spectrometry |
| 08/03/2006 | WO2006032432A3 Donepezyl salts |
| 08/03/2006 | US20060173188 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 08/03/2006 | US20060173107 for protecting organic materials, in particular synthetic polymers, against oxidative, thermal, dynamic, light-induced and/or ozone-induced degradation |
| 08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
| 08/03/2006 | US20060173044 Substituted propargylamines |
| 08/03/2006 | US20060173042 Process for the preparation of fexofenadine |
| 08/03/2006 | US20060173041 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/03/2006 | US20060173004 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2006 | US20060172990 Antibacterial agents |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2592608A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685108A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685107A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685106A2 Fexofendadine crystal form and processes for its preparation thereof |
| 08/02/2006 | EP1685105A1 Allosteric modulators of metabotropic glutamate receptors |
| 08/02/2006 | EP1685103A1 3-aminopyrrolidone derivatives |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |
| 08/02/2006 | EP1684759A2 4-phenyl piperdine sulfonyl glycine transporter inhibitors |
| 08/02/2006 | EP1684757A1 Substituted piperidines for the treatment of metabolic syndrome |
| 08/02/2006 | EP1684754A1 Hmg-coa reductase inhibitors and method |
| 08/02/2006 | EP1556045B1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 08/02/2006 | EP1434766B1 Piperidine compounds as muscarinic antagonists |
| 08/02/2006 | EP1409458B1 Method for preparing 4-amino-4-phenylpiperidines |
| 08/02/2006 | EP1409457B1 Method for preparing 4-methylamino-4-phenylpiperidine |
| 08/02/2006 | EP1140811B1 Novel herbicides |
| 08/02/2006 | EP1076057B1 Febrifugine and isofebrifugine and processes for the preparation of both |
| 08/02/2006 | EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/02/2006 | CN1812967A Cathepsin cysteine protease inhibitors |
| 08/02/2006 | CN1812964A Heterocyclic methyl sulfone derivative |
| 08/02/2006 | CN1812790A 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267417C Compound of fluorene class containing dual hetero atoms as well as its synthetic method and application |
| 08/01/2006 | US7084277 Reacting 1-alkoxycarbonyl-3-oxo piperidine compound with an amine; reducing with reducing agent |
| 08/01/2006 | US7084165 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 08/01/2006 | US7084158 Substituted propargylamines |
| 08/01/2006 | US7084154 Reducing pain |
| 08/01/2006 | US7084144 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | US7084090 Catalyst comprised of n-substituted cyclic imides and processes for preparing organic compounds with the catalyst |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/27/2006 | WO2006078619A1 Insecticidal heterocyclic 1,4-disubstituted benzene n-oxides |
| 07/27/2006 | WO2006077026A1 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-i) inhibitors for the treatment of neurological and neuropsychiatry disorders |
| 07/27/2006 | WO2006076797A1 Cathepsin k inhibitors and atherosclerosis |
| 07/27/2006 | WO2006035433A3 Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
| 07/27/2006 | US20060167265 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 07/27/2006 | US20060167244 Polymerisation inhibitor |
| 07/27/2006 | US20060167054 Tumor necrosis factor (TNF alpha) inhibitors for treatinginflammatory/infectious/autoimmune/proliferative diseases; anticancer/tumor/diabetic/arthritic agents |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167051 Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167008 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/27/2006 | US20060166962 2-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methyl}1-oxypiperazinyl)methyl]phenoxy}pyrimidine; insecticide, controlling tobacco budworm, wheat, corn, soybeans, potatoes, and cotton; for soil-borne insects, such as termites and white grubs |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
| 07/27/2006 | US20060165916 Cyanopyridone derivatives as liquid crystals |
| 07/27/2006 | US20060165648 Compounds, compositions, and methods for controlling biofilms |
| 07/27/2006 | CA2601326A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1(glyt-i) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/26/2006 | EP1682506A1 Dipeptide-analogue synthesis |
| 07/26/2006 | EP1682505A1 Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography |
| 07/26/2006 | EP1682504A2 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/26/2006 | EP1682503A2 Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/26/2006 | EP1682141A1 4-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 07/26/2006 | EP1682134A2 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 07/26/2006 | EP1244451B1 Substituted piperazine and piperidine calcium channel blockers |
| 07/26/2006 | CN1809553A Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |